Document is current
Any future updates will be listed below
-
Authors
Elkrief, Arielle
Pidgeon, Reilly https://orcid.org/0000-0002-7372-526X
Maleki Vareki, Saman https://orcid.org/0000-0002-9615-7779
Messaoudene, Meriem
Castagner, Bastien https://orcid.org/0000-0002-9207-1329
Routy, Bertrand https://orcid.org/0000-0003-1955-9149
- License Information
-
More Information
Article History
Accepted: 25 April 2025
First Online: 2 June 2025
Competing interests
: A.E. declares research funding from AstraZeneca, Merck,Kanvas Bioscience, and GMT Science; declares consulting/honoraria fees from AstraZeneca, Merck and BMS; and is an inventor on patent microbiome and immunotherapy patent no. 4872-8531-1934.1. S.M.V. was a member of the Board of Directors at IMV Inc. and declares consulting fees from Kanvas and FedBio. R.P., M.M., B.C. and B.R. are inventors on patent WO2021163802A1. B.R. has received research funding from Davolterra and Kanvas Bioscience; has received consulting fees from Merck, AstraZeneca, Vendata and BMS; and is the co-founder of Curebiota.
